Latest Information Update: 31 Jul 2012
At a glance
- Originator NicOx
- Class Aminosalicylic acids; Anti-inflammatories
- Mechanism of Action Free radical scavengers; Nitric oxide donors; Nitric oxide synthase type II inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Inflammatory bowel diseases